Quality of life in women with migraine: a systematic review
Abstract
Introduction: Several chronic diseases interfere with quality of life (QoL), including migraine, especially in women who are the most affected. However, effective therapeutic interventions are capable of modifying the disease. Objective: Our objective was to review the literature on QoL in women with migraine, before and after treatment. Methods: This study was a systematic review of clinical trials on migraine in women and QoL published between November 2019 and October 2024. The research was carried out in the online database PubMed, using the descriptors “migraine in women” and “quality of life”. Results: Eight articles were analyzed. They described 1,337 women with migraine aged 18 to 50 years. There was an improvement in QoL after therapeutic intervention, both drug and non-drug. Conclusions: Women with migraine have their QoL impaired, but therapeutic interventions can modify the disease.
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,337 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.